Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 737.00

+4.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry Liebman who wrote (199)	1/26/1998 1:29:00 PM
From: scaram(o)uche	Read Replies (2) of 3559

Larry: I feel that you buy a lot of science and leverage (big funding tied to projects where significant rights are retained) for $8. IMO, REGN belongs in a basket of biotechs where business plans are in play, backed by innovation and pointing toward good markets. Compelling reason "not" to have a position at these prices? No, not in my opinion. I haven't done much trading lately, but I added to my REGN position this morning. Potential (not compelling at this point) negative...... at $7 7/8 asked, it's certain that the angiopoietins aren't making anyone's radar and that obesity is not flying. Competitive work with bFGF, VEGF-1 and VEGF-2 is advanced with respect to ang1. MZ.... other than angiogenesis, which programs excite you most? MuSK certainly is quiet. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next